Sabinsa (East Windsor, NJ) was recognized by the United States Pharmacopeia (USP) for providing candidate documentary and reference standards that assisted USP in reaching important milestones in 2023. USP’s Certificate of Appreciation also acknowledged Sabinsa’s outstanding contributions toward global public health though the advancement of USP standards.

The Sami-Sabinsa Group, which has been working with USP for more than 20 years on projects related to reference standards, has been a consistent source for USP of reference standards for the herbal industry, including all the three actives of curcuminoids.

Reference standards are meticulously characterized substances utilized to assess the identity, potency, quality and purity of dietary supplement and active pharmaceutical ingredients, according to Sabinsa. They are the most critical requirement of any quantitative or qualitative analysis, without which one cannot provide a standardized product.

“The Sami-Sabinsa Group manufactures and promotes standardized products with innovative molecules worldwide and understands the requirements when it comes to testing such molecules,” said Asha Ramesh, CEO of Sabinsa US. “We stepped up in providing unmatched quality reference standards to USP, a worldwide accepted, independent scientific nonprofit organization which is focused on building trust in the supply of safe, high-quality ingredients for dietary supplements.”

For more information, visit www.sabinsa.com or www.sami-sabinsagroup.com.